An interpretable multiparametric radiomics model of basal ganglia to predict dementia conversion in Parkinson's disease
- PMID: 37648733
- PMCID: PMC10468504
- DOI: 10.1038/s41531-023-00566-1
An interpretable multiparametric radiomics model of basal ganglia to predict dementia conversion in Parkinson's disease
Abstract
Cognitive impairment in Parkinson's disease (PD) severely affects patients' prognosis, and early detection of patients at high risk of dementia conversion is important for establishing treatment strategies. We aimed to investigate whether multiparametric MRI radiomics from basal ganglia can improve the prediction of dementia development in PD when integrated with clinical profiles. In this retrospective study, 262 patients with newly diagnosed PD (June 2008-July 2017, follow-up >5 years) were included. MRI radiomic features (n = 1284) were extracted from bilateral caudate and putamen. Two models were developed to predict dementia development: (1) a clinical model-age, disease duration, and cognitive composite scores, and (2) a combined clinical and radiomics model. The area under the receiver operating characteristic curve (AUC) were calculated for each model. The models' interpretabilities were studied. Among total 262 PD patients (mean age, 68 years ± 8 [standard deviation]; 134 men), 51 (30.4%), and 24 (25.5%) patients developed dementia within 5 years of PD diagnosis in the training (n = 168) and test sets (n = 94), respectively. The combined model achieved superior predictive performance compared to the clinical model in training (AUCs 0.928 vs. 0.894, P = 0.284) and test set (AUCs 0.889 vs. 0.722, P = 0.016). The cognitive composite scores of the frontal/executive function domain contributed most to predicting dementia. Radiomics derived from the caudate were also highly associated with cognitive decline. Multiparametric MRI radiomics may have an incremental prognostic value when integrated with clinical profiles to predict future cognitive decline in PD.
© 2023. Springer Nature Limited.
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
Radiomics incorporating deep features for predicting Parkinson's disease in 123I-Ioflupane SPECT.EJNMMI Phys. 2024 Jul 10;11(1):60. doi: 10.1186/s40658-024-00651-1. EJNMMI Phys. 2024. PMID: 38985382 Free PMC article.
-
Development and Validation of a Plasma FAM19A5 and MRI-Based Radiomics Model for Prediction of Parkinson's Disease and Parkinson's Disease With Depression.Front Neurosci. 2021 Dec 17;15:795539. doi: 10.3389/fnins.2021.795539. eCollection 2021. Front Neurosci. 2021. PMID: 34975391 Free PMC article.
-
Parkinson's Disease Diagnosis Using Neostriatum Radiomic Features Based on T2-Weighted Magnetic Resonance Imaging.Front Neurol. 2020 Apr 8;11:248. doi: 10.3389/fneur.2020.00248. eCollection 2020. Front Neurol. 2020. PMID: 32322236 Free PMC article.
-
Radiomics and Hybrid Models Based on Machine Learning to Predict Levodopa-Induced Dyskinesia of Parkinson's Disease in the First 6 Years of Levodopa Treatment.Diagnostics (Basel). 2023 Jul 27;13(15):2511. doi: 10.3390/diagnostics13152511. Diagnostics (Basel). 2023. PMID: 37568874 Free PMC article.
-
Multivariate radiomics models based on 18F-FDG hybrid PET/MRI for distinguishing between Parkinson's disease and multiple system atrophy.Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3469-3481. doi: 10.1007/s00259-021-05325-z. Epub 2021 Apr 7. Eur J Nucl Med Mol Imaging. 2021. PMID: 33829415 Clinical Trial.
Cited by
-
Risk factors and predictors for Lewy body dementia: a systematic review.NPJ Dement. 2025;1(1):20. doi: 10.1038/s44400-025-00022-2. Epub 2025 Aug 4. NPJ Dement. 2025. PMID: 40771713 Free PMC article.
-
Radiomics-based Modelling Unveils Cerebellar Involvement in Parkinson's Disease.Cerebellum. 2025 Feb 18;24(2):48. doi: 10.1007/s12311-025-01797-z. Cerebellum. 2025. PMID: 39964592
-
The application of radiomics in the diagnosis and evaluation of cognitive impairment related to neurological diseases.Front Neurosci. 2025 Jul 2;19:1591605. doi: 10.3389/fnins.2025.1591605. eCollection 2025. Front Neurosci. 2025. PMID: 40672869 Free PMC article. Review.
-
Habitat analysis of iron deposition in the basal ganglia for diagnosing cognitive impairment in chronic kidney disease: evidence from a case-control study.BMC Med Imaging. 2025 Apr 8;25(1):113. doi: 10.1186/s12880-025-01656-7. BMC Med Imaging. 2025. PMID: 40200199 Free PMC article.
-
Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks.Int J Mol Sci. 2023 Dec 29;25(1):498. doi: 10.3390/ijms25010498. Int J Mol Sci. 2023. PMID: 38203667 Free PMC article. Review.
References
-
- Hely MA, et al. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov. Disord. 2008;23:837–844. - PubMed
-
- Williams-Gray CH, et al. Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain. 2007;130:1787–1798. - PubMed
-
- Stoessl AJ, Martin WRW, McKeown MJ, Sossi V. Advances in imaging in Parkinson’s disease. Lancet Neurol. 2011;10:987–1001. - PubMed
-
- McKinlay A, Grace RC, Dalrymple-Alford JC, Roger D. Characteristics of executive function impairment in Parkinson’s disease patients without dementia. J. Int. Neuropsychol. Soc. 2010;16:268–277. - PubMed
-
- Chung SJ, et al. Effect of striatal dopamine depletion on cognition in de novo Parkinson’s disease. Parkinsonism Relat. Disord. 2018;51:43–48. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources